BioWorld MedTech

April 20, 2016

JNJ kicks off 2016 with strong Q1, but device biz may get a Band-Aid

Johnson & Johnson(J&J) reported a strong first quarter overall, beating quarterly earnings forecasts on prescription drug revenue, but the company's medical device business has seen better days. Read More

The new kid on China's block, ophthalmology market enjoys boom

Ontario startup offers pragmatic tool for low cost hip replacement

CMS skeptical about new tech add-on for Edwards Intuity valve

Other news to note

Financings

Product Briefs

Keeping you up to date on recent developments in oncology

Today's news in brief

BioWorld

BioWorld briefs for March 19, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...